which may lead to serious postoperative bleeding are more commonly associated with certain cephalosporins having the N-methylthiotetrazole side chain-' but have been noted with others -such as cefuroxime - We thank Mrs C Finan, Sister S Walsh, Mrs J Davies, and Miss J Hannington for valuable help with the trial documentation. We are also grateful to Mr P J Thomas for advising on the group sequential study design, Miss Kathryn Legge for performing the statistical analysis, and Miss Helen Moore for word processing the manuscript. Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery. In a six week survey of 136 beds a pharmacist examined patient records for adverse reactions and collected reports from nurses and prescribers who had been circulated with guidelines on reporting drug side effects. Thirty eight reactions were detected among 706 patients (5 4%), most (21) from patient records; eight were reported by nurses but only three by prescribers (the rest came from a combination of sources).
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In a six week survey of 136 beds a pharmacist examined patient records for adverse reactions and collected reports from nurses and prescribers who had been circulated with guidelines on reporting drug side effects. Thirty eight reactions were detected among 706 patients (5 4%), most (21) from patient records; eight were reported by nurses but only three by prescribers (the rest came from a combination of sources).
We then offered IR£3 to junior doctors for each completed yellow card given to a designated registrar. Within six weeks 150 reports had been received (an incidence of9 7%). These included two drug associated deaths (streptokinase anaphylaxis, pentamidine pancreatitis) and 27 serious or life threatening' reactions -for example, bone marrow suppression, arrhythmias, gastrointestinal haemorrhage, warfarin interaction, pseudomembranous colitis, hepatotoxicity, and the 22 BMJ VOLUME 300 6 JANUARY 1990 Stevens-Johnson syndrome. An independent assessment of a random 25% sample confirmed the reports in over 90% of cases. A survey of the 40 reporting doctors identified "forgot/too busy" (4), unavailability of forms (18) , and uncertainty about reporting system (6) as main constraints in reporting. The fee was an incentive for 32. In the six weeks after withdrawal of the fee only 30 reports were received by the registrar.
Comment
Enhanced rates of reporting drug reactions will improve overall drug assessment, reduce bias, and speed earlier detection of serious toxicity with new drugs. Over the past six years our 800 bed hospital (15 000 admissions yearly) has generated almost 0 2% yellow cards per patient. Offering a fee increased the rate of reporting by almost 50-fold, to 9 7%, whereas the pharmacist's survey detected a rate (5 4%) comparable to that in previous studies.' Nevertheless, it identified a potential source of additional reportsnurses.
In the fee study we were unable to distinguish the value of reporting to an individual colleague, which we believe to be important, and the contribution of the fee, but the number of reports fell substantially after withdrawal of the fee. Two constraints -availability of vellow cards and lack of information on what to report-should be remediable. To counter the main constraint, "lack of time/forgetfulness," we can try only to ensure that reporting of reactions becomes an integral part of patient care.
Reporting fees are used in collecting other medical information such as notifiable diseases. We regard the use of a fee to stimulate reporting as an additional tool in drug assessment. Not only did use of the fee greatly enhance the number of reports, producing almost the equivalent to the previous six years' reports within six weeks; it also revealed many serious reactions, including those associated with newer treatments. In the normal course of events these reactions go unreported. We also introduced recently qualified doctors to the reporting system: 48% of the target group (in our case junior doctors) reported reactions over six weeks compared with a figure of 16% over 10 years for the current system.' Further evaluation of the use of a reporting fee is warranted.
We thank the staff of St James's Hospital and the National Drugs Advisory Board for their cooperation. Patients, methods, and results A detailed community based record has been created for all pregnancies in women with the above risk factors whose HIV antibody state is known.' 2 Great care is taken to ensure both completeness and confidentiality of this record. We excluded pregnancies that spontaneously aborted, those confirmed before January 1986, and those in women who did not know before 22 weeks or termination whether they were positive for HIV antibodies. We thus studied 163 pregnancies. Standard counselling was provided by several doctors and counsellors.
Induced abortion was common in both the women with and without HIV antibodies (table) . Although a higher proportion of the women with HIV antibodies had induced abortions, the difference was not significant (x2C= 1-22, p>020). Forty four women knew that they were positive for HIV antibodies when they became pregnant, and 21 of these had the pregnancy terminated. HIV infection was the main or only reason for termination in at least nine pregnancies: two of the women had AIDS and two had other illness related to HIV infection. Twenty five women were found to have HIV antibodies during pregnancy and knew the result before 22 weeks. Ten of these women had termination of pregnancy, but nine had previously requested abortion on other grounds and had been tested at that consultation. All 
The combination of pregnancy and HIV infection can necessitate difficult decisions. The women we studied had a high rate of induced abortion, whether or not they were infected with HIV; the rate was nearly three times that in the city's overall population. Finding during pregnancy that they had HIV anti-
